About Tejnaksh Healthcare Ltd
Tejnaksh Healthcare engaged in the provision hospital and healthcare service in Mumbai and other parts of Maharashtra.
Founded
2008
CEO
Ashish Vishwas Rawandale
Employees
42
HQ
Dhule, India
Finished Products
1Operations & Surgery
₹8.28Cr2Pathology
₹3.16Cr3Traded Goods
₹2.95Cr4Consultation Charges
₹2.16Cr5Other Operating Income
₹0.47CrRaw Materials
1Purchase of Stock-in-Trade
₹0.62Cr2Medical consumables and Drugs
₹0.57Cr3Raw Material Consumed
₹0.16CrAbout Tejnaksh Healthcare Ltd
Tejnaksh Healthcare engaged in the provision hospital and healthcare service in Mumbai and other parts of Maharashtra.
Founded:2008
CEO:Ashish Vishwas Rawandale
Employees:42
HQ:Dhule, India
Finished Products
1Operations & Surgery
₹8.28Cr2Pathology
₹3.16Cr3Traded Goods
₹2.95Cr4Consultation Charges
₹2.16Cr5Other Operating Income
₹0.47CrRaw Materials
1Purchase of Stock-in-Trade
₹0.62Cr2Medical consumables and Drugs
₹0.57Cr3Raw Material Consumed
₹0.16CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹20
52W Low
₹11
Volume877
Avg VolumeN/A
Beta0.76
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
22.21x
Valuation
P/B Ratio
1.01x
Valuation
EPS
₹0.61
Valuation
Dividend Yield
0.00%
Valuation
ROE
4.52%
Profitability
ROCE
6.35%
Profitability
Revenue by Segment
Contribution & growth by business line
Healthcare ServicesRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.01x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
3.2%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.